Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2026-01-04 @ 11:57 AM
Study NCT ID:
NCT00403195
Status:
COMPLETED
Last Update Posted:
2012-09-10
First Post:
2006-11-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical and Pathophysiological Description of Ocular Ischemic Syndrome
Sponsor:
Glostrup University Hospital, Copenhagen
Organization:
Study Overview
Official Title:
Pathophysiological Analysis of Ocular Ischemic Syndrome and the Response to Vascular Surgery
Status:
COMPLETED
Status Verified Date:
2012-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to characterize the disease Ocular Ischemic Syndrome.
Detailed Description:
The disease Ocular Ischemic Syndrome (OIS) is not a well described entity. It occurs after a long-standing period of extremely low blood supply to the retina caused by atherosclerosis of the carotid arteries. In this study we will analyze why OIS is developed in some patients and not developed in others. The patients with OIS will be thorough examined and will be compared with 1) a control group of healthy people and 2) with control group of patients with diabetic retinopathy. Furthermore the impact of vascular surgery on OIS will be analyzed.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: